A systematic review of treatments for refractory depression in older people

American Journal of Psychiatry

Volumn 168, Issue 7, 2011, Pages 681-688

  Cooper, Claudia ^a   Katona, Cornelius ^a   Lyketsos, Kostas ^a   Blazer, Dan ^a   Brodaty, Henry ^a   Rabins, Peter ^a   De Mendonça Lima, Carlos Augusto ^a   Livingston, Gill ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANALGESIC AGENT; ARIPIPRAZOLE; CITALOPRAM; DULOXETINE; HALOPERIDOL; LITHIUM; NORTRIPTYLINE; PAROXETINE; PHENELZINE; PLACEBO; RISPERIDONE; SELEGILINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ABSENCE OF SIDE EFFECTS; AGED; AKATHISIA; BLOATING; CLINICAL GLOBAL IMPRESSION SCALE; COGNITIVE DEFECT; DEPRESSION; DIARRHEA; DRUG DOSE TITRATION; DRUG MEGADOSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; FATIGUE; GERIATRIC PATIENT; HAMILTON SCALE; HUMAN; HYPOTENSION; INSOMNIA; MANIA; MEMORY DISORDER; MONTGOMERY ASBERG DEPRESSION RATING SCALE; PRIORITY JOURNAL; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEDATION; SIDE EFFECT; SWEATING; SYSTEMATIC REVIEW; TREATMENT RESPONSE; TREMOR; UNSPECIFIED SIDE EFFECT; WEAKNESS; XEROSTOMIA;

ADULT; AGE FACTORS; AGED; ANTIDEPRESSIVE AGENTS; CLINICAL TRIALS AS TOPIC; DEPRESSIVE DISORDER, MAJOR; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; LITHIUM COMPOUNDS; MALE; META-ANALYSIS AS TOPIC; MIDDLE AGED; POLYPHARMACY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 79960510107     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2011.10081165     Document Type: Review

References (31)

1. Chapman DP, Perry GS: Depression as a major component of public health for older adults. Prev Chronic Dis 2008; 5:A22
2. Stimpson N, Agrawal N, Lewis G: Randomised controlled trials investigating pharmacological and psychological interventions for treatment-refractory depression: systematic review. Br J Psychiatry 2002; 181:284-294 (Pubitemid 35178559)
3. Nemeroff CB: Prevalence and management of treatment-resistant depression. J Clin Psychiatry 2007; 68:17-25
4. Goldberg D, Privett M, Ustun B, Simon G, Linden M: The effects of detection and treatment on the outcome of major depression in primary care: a naturalistic study in 15 cities. Br J Gen Pract 1998; 48:1840-1844 (Pubitemid 28552140)
5. Alexopoulos GS: Depression in the elderly. Lancet 2005; 365:1961-1970
6. Harman JS, Mulsant BH, Kelleher KJ, Schulberg HC , Kupfer DJ, Reynolds CF: Narrowing the gap in treatment of depression. Int J Psychiatry Med 2001; 31:239-253 (Pubitemid 34112927)
7. McPherson S, Cairns P, Carlyle J, Shapiro DA, Richardson P, Taylor D: The effectiveness of psychological treatments for treatment- resistant depression: a systematic review. Acta Psychiatr Scand 2005; 111:331-340 (Pubitemid 40604334)
8. Taylor D, Paton C , Kerwin R: Treatment of refractory depression, in The Maudsley Guidelines, 9th ed. Edited by Taylor D, Paton C , Kerwin R. London, Informa Healthcare, 2007, pp 193-196
9. Krishnan KRR: Neuroanatomical substrates of depression in the elderly. J Geriatr Psychiatry Neurol 1993; 6:39-58
10. Livingston G, Johnston K, Katona C , Paton J, Lyketsos CG, Old Age Task Force of the World Federation of Biological Psychiatry: Systematic review of psychological approaches to the management of neuropsychiatric symptoms of dementia. Am J Psychiatry 2005; 162:1996-2021 (Pubitemid 41598254)
11. Selwood A, Johnston K, Katona C , Lyketsos C , Livingston G: Systematic review of the effect of psychological interventions on family caregivers of people with dementia. J Affect Disord 2007; 101:75-89 (Pubitemid 46887614)
12. StatsDirect: StatsDirect Statistical Software, version 2.6.6. Cheshire, UK, StatsDirect, 2008
13. Alexopoulos GS, Canuso CM, Gharabawi GM, Bossie CA, Greenspan A, Turkoz I, Reynolds C: Placebo-controlled study of relapse prevention with risperidone augmentation in older patients with resistant depression. Am J Geriatr Psychiatry 2008; 16:21-30
14. Dew MA, Whyte EM, Lenze EJ, Houck PR, Mulsant BH, Pollock BG, Stack JA, Bensasi S, Reynolds CF: Recovery from major depression in older adults receiving augmentation of antidepressant pharmacotherapy. Am J Psychiatry 2007; 164:892-899 (Pubitemid 46972904)
15. Whyte EM, Basinski J, Farhi P, Dew MA, Begley A, Mulsant BH, Reynolds CF: Geriatric depression treatment in nonresponders to selective serotonin reuptake inhibitors. J Clin Psychiatry 2004; 65:1634-1641
16. Finch EJL, Katona CLE: Lithium augmentation in the treatment of refractory depression in old age. Int J Geriatr Psychiatry 1989; 4:41-46 (Pubitemid 19029118)
17. Flint AJ, Rifat SL: The effect of sequential antidepressant treatment on geriatric depression. J Affect Disord 1996; 36:95-105 (Pubitemid 26040157)
18. Flint AJ, Rifat SL: The treatment of psychotic depression in later life: a comparison of pharmacotherapy and ECT. Int J Geriatr Psychiatry 1998; 13:23-28 (Pubitemid 28046026)
19. Karp JF, Whyte EM, Lenze EJ, Dew MA, Begley A, Miller MD, Reynolds CF III: Rescue pharmacotherapy with duloxetine for selective serotonin reuptake inhibitor nonresponders in late-life depression: outcome and tolerability. J Clin Psychiatry 2008; 69:457-463 (Pubitemid 351549400)
20. Kok RM, Vink D, Heeren TJ, Nolen WA: Lithium augmentation compared with phenelzine in treatment-resistant depression in the elderly: an open, randomized, controlled trial. J Clin Psychiatry 2007; 68:1177-1185 (Pubitemid 47395619)
21. Kok RM, Nolen WA, Heeren TJ: Outcome of late-life depression after 3 years of sequential treatment. Acta Psychiatr Scand 2009; 119:274-281
22. Lafferman J, Solomon K, Ruskin P: Lithium augmentation for treatment-resistant depression in the elderly. J Geriatr Psychiatry Neurol 1988; 1:49-52 (Pubitemid 19134023)
23. Mazeh D, Shahal B, Aviv A, Zemishlani H, Barak Y: A randomized single-blind comparison of venlafaxine with paroxetine in elderly patients suffering from resistant depression. Int Clin Psychopharmacol 2007; 22:371-375 (Pubitemid 47530842)
24. Sheffrin M, Driscoll HC , Lenze EJ, Mulsant BH, Pollock BG, Mil ler MD, Butters MA, Dew MA, Reynolds CF: Pilot study of augmentation with aripiprazole for incomplete response in latelife depression: getting to remission. J Clin Psychiatry 2009; 70:208-213
25. Sunderland T, Cohen RM, Molchan S, Lawlor BA, Mellow AM, Newhouse PA, Tariot PN, Mueller EA, Murphy DL: High-dose selegiline in treatment-resistant older depressive patients. Arch Gen Psychiatry 1994; 51:607-615 (Pubitemid 24249102)
26. Zimmer B, Rosen J, Thornton JE, Perel JM, Reynolds CF III: Adjunctive lithium carbonate in nortriptyline-resistant elderly depressed patients. J Clin Psychopharmacol 1991; 11:254-256
27. Higgins JPT, Thompson SG, Deeks JJ, Altman DG: Measuring inconsistency in meta-analyses. Br M ed J 2003; 327:557-560 (Pubitemid 37088507)
28. Egger M, Smith GD, Schneider M, Minder C: Bias in meta-analysis detected by a simple, graphical test. Br Med J 1997; 315:629-634 (Pubitemid 27387172)
29. Bauer M, Dopfmer S: Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies. J Clin Psychopharmacol 1999; 19:427-434 (Pubitemid 29451507)
30. Nierenberg AA, Fava M, Trivedi MH, Wisniewski SR, Thase ME, McGrath PJ, Alpert JE, Warden D, Luther JF, Niederehe G, Lebowitz B, Shores-W ilson K, Rush AJ, STAR*D Study Team: A comparison of lithium and T3 augmentation following two failed medication treatments for depression: a STAR*D report. Am J Psychiatry 2006; 163:1519-1530
31. Wijeratne C , Sachdev P: Treatment-resistant depression: critique of current approaches. Aust N Z J Psychiatry 2008; 42:751-762